VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 125 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $822,518 | -8.7% | 62,030 | +29.2% | 0.00% | – |
| Q2 2023 | $900,413 | +9.4% | 48,022 | -15.8% | 0.00% | – |
| Q1 2023 | $822,805 | +3.0% | 57,060 | +38.2% | 0.00% | – |
| Q4 2022 | $799,000 | -46.7% | 41,294 | -5.3% | 0.00% | -100.0% |
| Q3 2022 | $1,498,000 | +135.2% | 43,609 | +4.5% | 0.00% | – |
| Q2 2022 | $637,000 | -10.7% | 41,715 | +33.5% | 0.00% | – |
| Q1 2022 | $713,000 | -30.9% | 31,253 | +11.6% | 0.00% | – |
| Q4 2021 | $1,032,000 | -23.3% | 27,998 | -2.1% | 0.00% | – |
| Q3 2021 | $1,345,000 | -15.0% | 28,608 | +8.9% | 0.00% | – |
| Q2 2021 | $1,583,000 | – | 26,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |